BiomX Inc. (PHGE) - Latest Market Data

Price & Market Data

Price: $0.817

Daily Change: +$0.0776 / 9.50%

Daily Range: $0.62 - $1.20

Market Cap: $8,256,053

Daily Volume: 19,168,361

Performance Metrics

1 Week: 45.27%

1 Month: -39.31%

3 Months: -82.61%

6 Months: -83.81%

1 Year: -90.97%

YTD: -53.05%

About BiomX Inc. (PHGE)

Keep track of BiomX Inc. (PHGE)'s market journey. Priced at 0.817, the stock reflects a daily movement of +$0.0776 / 9.50%. With a market cap of 8,256,053, explore its full spectrum of performance from YTD to 1-year.

Company Details

Employees: 20

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.

Selected stocks

Westport Fuel Systems Inc (WPRT)

Lexicon Pharmaceuticals, Inc. (LXRX)

S&P 500 ETF (SPY)

SurgePays, Inc. (SURG)

Alpha Teknova, Inc. (TKNO)